M. V. van Ruler

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone

A. Llombart‐Bosch, P. Hogendoorn, D. de Jong, 2012, BMC Cancer.

Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.

A. Flanagan, P. Picci, P. Hogendoorn, 2013, The American journal of pathology.

Somatic mosaic IDH1 or IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

R. Sciot, M. Vikkula, C. Godfraind, 2011, Nature Genetics.

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors

A. Cleton-Jansen, W. Richter, J. Bovée, 2012, BMC Cancer.

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells

B. van de Water, H. Gelderblom, B. Herpers, 2013, British Journal of Cancer.

R132C IDH1 mutations are found in spindle cell hemangiomas and not in other vascular tumors or malformations.

R. Sciot, A. Lazar, C. Fletcher, 2013, American Journal of Pathology.

BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors

A. Cleton-Jansen, W. Richter, J. Bovée, 2012, BMC Cancer.

Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.

A. Flanagan, P. Picci, P. Hogendoorn, 2013, The American journal of pathology.